EmployblEmploybl logo
employbl
Chroma Medicine logo

Chroma Medicine Funding & Investors

Chroma Medicine is a new genomic medicine company working on epigenetic editing. Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, to revolutionize the treatment of genetically driven diseases.

chromamedicine.com

Total Amount Raised: $260,000,000

Chroma Medicine Funding Rounds

  • Series B

    $135,000,000

    Series B Investors

    GV
    Casdin Capital
    T. Rowe Price
    Cormorant Asset Management
    Sofinnova Partners
    OUP (Osage University Partners)
    Arch Venture Partners
    Omega Funds
    Alexandria Venture Investments
    Henderson Global Investors
    Wellington Management
    DCVC Bio
    Mubadala Capital Ventures
    Atlas Venture
    Newpath Management
    Sixth Street

  • Series A

    $125,000,000

    Series A Investors

    Cormorant Asset Management
    Henderson Global Investors
    Wellington Management
    T. Rowe Price
    Omega Funds
    Casdin Capital
Funding info provided by Diffbot.